1. Janson C, Chinn S, Jarvis D, Zock JP, Torén K, Burney P, et al. Effect of passive smoking on respiratory symptoms, bronchial responsiveness, lung function, and total serum IgE in the European Community Respiratory Health Survey: a cross-sectional study. Lancet. 2001; 358(9299):2103–2109.
Article
2. Ha KC, Paik NW, Park DU, Yoon CS, Kim W, Choi SJ, et al. A study on indicators for environmental tobacco smoke at indoor office environments. J Korean Soc Occup Environ Hyg. 2003; 13(2):152–159.
3. Eisner MD, Klein J, Hammond SK, Koren G, Lactao G, Iribarren C. Directly measured second hand smoke exposure and asthma health outcomes. Thorax. 2005; 60(10):814–821.
Article
4. Eisner MD, Wang Y, Haight TJ, Balmes J, Hammond SK, Tager IB. Secondhand smoke exposure, pulmonary function, and cardiovascular mortality. Ann Epidemiol. 2007; 17(5):364–373.
Article
5. Health effects of exposure to environmental tobacco smoke. California Environmental Protection Agency. Tob Control. 1997; 6(4):346–353.
6. Dome P, Lazary J, Kalapos MP, Rihmer Z. Smoking, nicotine and neuropsychiatric disorders. Neurosci Biobehav Rev. 2010; 34(3):295–342.
Article
7. Hamer M, Stamatakis E, Batty GD. Objectively assessed secondhand smoke exposure and mental health in adults: cross-sectional and prospective evidence from the Scottish Health Survey. Arch Gen Psychiatry. 2010; 67(8):850–855.
8. Gim W, Yoo JH, Shin JY, Goo AJ. Relationship between secondhand smoking with depressive symptom and suicidal ideation in Korean non-smoker adults: the Korean national health and nutrition examination survey 2010-2012. Korean J Fam Med. 2016; 37(2):97–104.
Article
9. Kang SY, Cho YH, Jeong DW, Lee SY, Kim YJ, Lee JG, et al. Association between secondhand smoke and health-related quality of life in middle-aged Korean adults. Korean J Health Promot. 2015; 15(4):185–193.
Article
10. Haufroid V, Lison D. Urinary cotinine as a tobacco-smoke exposure index: a minireview. Int Arch Occup Environ Health. 1998; 71(3):162–168.
Article
11. Benowitz NL, Schultz KE, Haller CA, Wu AH, Danis KM, Jacob P 3rd. Prevalence of smoking assessed biochemically in an urban public hospital: a rationale for routine cotinine screening. Am J Epidemiol. 2009; 170(7):885–891.
Article
12. Goniewicz ML, Eisner MD, Lazcano-Ponce E, Zielinska-Danch W, Koszowski B, Sobczak A, et al. Comparison of urine cotinine and the tobacco-specific nitrosamine metabolite 4-(methylnitrosamino) -1-(3-pyridyl)-1-butanol (NNAL) and their ratio to discriminate active from passive smoking. Nicotine Tob Res. 2011; 13(3):202–208.
13. World Health Organization. Guidelines for controlling and monitoring the tobacco epidemic. Geneva: World Health Organization;1998.
14. Santos IS, Tavares BF, Munhoz TN, Almeida LSPD, Silva NTBD, Tams BD, et al. Sensitivity and specificity of the patient health questionnaire-9 (PHQ-9) among adults from the general population. Cad Saude Publica. 2013; 29(8):1533–1543.
15. Manea L, Gilbody S, McMillan D. Optimal cut-off score for diagnosing depression with the patient health questionnaire (PHQ-9): a meta-analysis. CMAJ. 2012; 184(3):E191–E196.
Article
16. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001; 16(9):606–613.
17. Lu Y, Marks MJ, Collins AC. Desensitization of nicotinic agonist-induced [3H]gamma-aminobutyric acid release from mouse brain synaptosomes is produced by subactivating concentrations of agonists. J Pharmacol Exp Ther. 1999; 291(3):1127–1134.
18. McGehee DS, Heath MJ, Gelber S, Devay P, Role LW. Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors. Science. 1995; 269(5231):1692–1696.
Article
19. Marshall DL, Redfern PH, Wonnacott S. Presynaptic nicotinic modulation of dopamine release in the three ascending pathways studied by in vivo microdialysis: comparison of naive and chronic nicotine-treated rats. J Neurochem. 1997; 68(4):1511–1519.
Article
20. Ribeiro EB, Bettiker RL, Bogdanov M, Wurtman RJ. Effects of systemic nicotine on serotonin release in rat brain. Brain Res. 1993; 621(2):311–318.
Article
21. Dagher A, Bleicher C, Aston JA, Gunn RN, Clarke PB, Cumming P. Reduced dopamine D1 receptor binding in the ventral striatum of cigarette smokers. Synapse. 2001; 42(1):48–53.
Article
22. Izenwasser S, Jacocks HM, Rosenberger JG, Cox BM. Nicotine indirectly inhibits [3H]dopamine uptake at concentrations that do not directly promote [3H]dopamine release in rat striatum. J Neurochem. 1991; 56(2):603–610.
23. Benwell ME, Balfour DJ. The effects of nicotine administration on 5-HT uptake and biosynthesis in rat brain. Eur J Pharmacol. 1982; 84(1-2):71–77.
Article
24. Pasco JA, Williams LJ, Jacka FN, Ng F, Henry MJ, Nicholson GC, et al. Tobacco smoking as a risk factor for major depressive disorder: population-based study. Br J Psychiatry. 2008; 193(4):322–326.
Article
25. Decramer M, Rennard S, Troosters T, Mapel DW, Giardino N, Mannino D, et al. COPD as a lung disease with systemic consequences-clinical impact, mechanisms, and potential for early intervention. COPD. 2008; 5(4):235–256.